New York State Common Retirement Fund Amgen Inc Transaction History

New York State Common Retirement Fund

  • $74.9 Billion
  • Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Amgen Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 625,139 shares of AMGN stock, worth $214 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
625,139
Previous 664,928 5.98%
Holding current value
$214 Million
Previous $186 Million 4.98%
% of portfolio
0.24%
Previous 0.26%

Shares

45 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025
SELL
$271.18 - $309.22 $10.8 Million - $12.3 Million
-39,789 Reduced 5.98%
625,139 $176 Million
Q2 2025

Oct 08, 2025
SELL
$262.28 - $309.85 $1.63 Million - $1.93 Million
-6,221 Reduced 0.93%
664,928 $186 Million
Q2 2025

Aug 13, 2025
SELL
$262.28 - $309.85 $1.63 Million - $1.93 Million
-6,221 Reduced 0.93%
664,928 $186 Million
Q1 2025

Oct 08, 2025
SELL
$258.59 - $327.36 $499,078 - $631,804
-1,930 Reduced 0.29%
671,149 $209 Million
Q1 2025

May 01, 2025
SELL
$258.59 - $327.36 $499,078 - $631,804
-1,930 Reduced 0.29%
671,149 $209 Million
Q4 2024

Oct 08, 2025
BUY
$258.78 - $328.31 $539,297 - $684,198
2,084 Added 0.31%
673,079 $175 Million
Q4 2024

Jan 31, 2025
BUY
$258.78 - $328.31 $539,297 - $684,198
2,084 Added 0.31%
673,079 $175 Million
Q3 2024

Oct 08, 2025
BUY
$309.38 - $337.38 $1.88 Million - $2.05 Million
6,067 Added 0.91%
670,995 $216 Million
Q3 2024

Oct 28, 2024
SELL
$309.38 - $337.38 $28.7 Million - $31.3 Million
-92,822 Reduced 12.15%
670,995 $216 Million
Q2 2024

Oct 08, 2025
BUY
$262.75 - $319.31 $26 Million - $31.6 Million
98,889 Added 14.87%
763,817 $239 Million
Q2 2024

Jul 31, 2024
SELL
$262.75 - $319.31 $718,884 - $873,632
-2,736 Reduced 0.36%
763,817 $239 Million
Q1 2024

Oct 08, 2025
BUY
$268.87 - $324.56 $27.3 Million - $33 Million
101,625 Added 15.28%
766,553 $218 Million
Q1 2024

May 07, 2024
SELL
$268.87 - $324.56 $5.81 Million - $7.01 Million
-21,611 Reduced 2.74%
766,553 $218 Million
Q4 2023

Oct 08, 2025
BUY
$255.7 - $288.46 $31.5 Million - $35.5 Million
123,236 Added 18.53%
788,164 $227 Million
Q4 2023

Feb 01, 2024
SELL
$255.7 - $288.46 $17.4 Million - $19.6 Million
-68,049 Reduced 7.95%
788,164 $227 Million
Q3 2023

Oct 08, 2025
BUY
$218.65 - $271.46 $41.8 Million - $51.9 Million
191,285 Added 28.77%
856,213 $230 Million
Q3 2023

Nov 07, 2023
SELL
$218.65 - $271.46 $8.35 Million - $10.4 Million
-38,178 Reduced 4.27%
856,213 $230 Million
Q2 2023

Oct 08, 2025
BUY
$214.27 - $253.37 $49.2 Million - $58.1 Million
229,463 Added 34.51%
894,391 $199 Million
Q2 2023

Aug 07, 2023
SELL
$214.27 - $253.37 $7.23 Million - $8.55 Million
-33,755 Reduced 3.64%
894,391 $199 Million
Q1 2023

Oct 08, 2025
SELL
$225.79 - $275.2 $9.99 Million - $12.2 Million
-44,255 Reduced 4.55%
928,146 $224 Million
Q1 2023

May 02, 2023
SELL
$225.79 - $275.2 $9.99 Million - $12.2 Million
-44,255 Reduced 4.55%
928,146 $224 Million
Q4 2022

Oct 08, 2025
BUY
$229.03 - $291.01 $70.4 Million - $89.5 Million
307,473 Added 46.24%
972,401 $255 Million
Q4 2022

Jan 30, 2023
SELL
$229.03 - $291.01 $581,049 - $738,292
-2,537 Reduced 0.26%
972,401 $255 Million
Q3 2022

Nov 08, 2022
SELL
$224.46 - $253.15 $11.2 Million - $12.6 Million
-49,969 Reduced 4.88%
974,938 $220 Million
Q2 2022

Aug 04, 2022
SELL
$230.71 - $256.74 $14.8 Million - $16.4 Million
-63,999 Reduced 5.88%
1,024,907 $249 Million
Q1 2022

May 05, 2022
SELL
$219.27 - $242.57 $2.91 Million - $3.22 Million
-13,279 Reduced 1.2%
1,088,906 $263 Million
Q4 2021

Feb 02, 2022
SELL
$198.88 - $227.6 $36,395 - $41,650
-183 Reduced 0.02%
1,102,185 $248 Million
Q3 2021

Nov 02, 2021
SELL
$212.27 - $248.7 $11 Million - $12.9 Million
-51,909 Reduced 4.5%
1,102,368 $234 Million
Q2 2021

Aug 02, 2021
SELL
$233.58 - $259.14 $14.5 Million - $16 Million
-61,913 Reduced 5.09%
1,154,277 $281 Million
Q1 2021

May 11, 2021
BUY
$221.91 - $258.6 $2.24 Million - $2.61 Million
10,100 Added 0.84%
1,216,190 $303 Million
Q4 2020

Feb 08, 2021
SELL
$216.38 - $257.67 $16 Million - $19.1 Million
-74,164 Reduced 5.79%
1,206,090 $277 Million
Q3 2020

Nov 05, 2020
SELL
$234.65 - $260.95 $16.6 Million - $18.4 Million
-70,552 Reduced 5.22%
1,280,254 $325 Million
Q2 2020

Aug 07, 2020
SELL
$197.81 - $242.74 $15.1 Million - $18.5 Million
-76,266 Reduced 5.34%
1,350,806 $319 Million
Q1 2020

May 06, 2020
SELL
$182.24 - $241.7 $1.42 Million - $1.89 Million
-7,800 Reduced 0.54%
1,427,072 $289 Million
Q4 2019

Feb 05, 2020
SELL
$189.21 - $243.2 $4.95 Million - $6.36 Million
-26,151 Reduced 1.79%
1,434,872 $346 Million
Q3 2019

Nov 07, 2019
SELL
$174.11 - $208.62 $17.1 Million - $20.5 Million
-98,100 Reduced 6.29%
1,461,023 $283 Million
Q2 2019

Aug 09, 2019
SELL
$166.7 - $195.41 $21.3 Million - $25 Million
-127,729 Reduced 7.57%
1,559,123 $287 Million
Q1 2019

May 08, 2019
SELL
$180.87 - $203.88 $4.99 Million - $5.63 Million
-27,591 Reduced 1.61%
1,686,852 $320 Million
Q4 2018

Feb 08, 2019
SELL
$178.4 - $208.25 $15.9 Million - $18.6 Million
-89,394 Reduced 4.96%
1,714,443 $334 Million
Q3 2018

Nov 07, 2018
SELL
$185.29 - $208.89 $8.75 Million - $9.86 Million
-47,220 Reduced 2.55%
1,803,837 $374 Million
Q2 2018

Aug 10, 2018
SELL
$166.05 - $186.51 $41 Million - $46 Million
-246,850 Reduced 11.77%
1,851,057 $342 Million
Q1 2018

May 10, 2018
SELL
$169.43 - $198.0 $12.8 Million - $15 Million
-75,824 Reduced 3.49%
2,097,907 $358 Million
Q4 2017

Feb 13, 2018
BUY
$168.79 - $188.59 $3.24 Million - $3.62 Million
19,197 Added 0.89%
2,173,731 $378 Million
Q3 2017

Nov 06, 2017
SELL
$167.29 - $191.0 $1.3 Million - $1.49 Million
-7,800 Reduced 0.36%
2,154,534 $402 Million
Q2 2017

Aug 11, 2017
BUY
N/A
2,162,334
2,162,334 $372 Million

Others Institutions Holding AMGN

# of Institutions
3,271
Shares Held
428M
Call Options Held
6.17M
Put Options Held
5.85M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email